Atlas Trials

Immediate Versus Deferred Cytoreductive Nephrectomy With Ipilimumab/Nivolumab in mRCC

Clinical trial NCT07233668 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07233668
Sponsor
Seoul National University Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Renal Cell Carcinoma ( mRCC)
Start date
2025-12-01
Primary completion
2028-10-01
Enrollment
172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.